Establishing causality in the assessment of safety of medicines for children

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 12, 2008, Pages 1611-1616

  Ashby, Deborah ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bradford hill criteria; Causality; Evidence synthesis; Medicines for children; Pharmacoepidemiology

Indexed keywords

ASSOCIATION; CHILD; CRITERION VARIABLE; DRUG SAFETY; DRUG USE; HUMAN; PEDIATRICS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

CAUSALITY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG TOXICITY; EVIDENCE-BASED MEDICINE; HUMANS; PEDIATRICS; PHARMACOEPIDEMIOLOGY; PRESCRIPTION DRUGS; TREATMENT OUTCOME;

EID: 55649092469     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.01026.x     Document Type: Review

References (21)

1. World Health Organization. Promoting safety of medicines for children. Geneva : World Health Organisation Press, 2007.
2. European Medicine Evaluation Agency. Commission guideline on the format and content of applications for agreement of modification of a paediatric investigation plan and requests for waivers or deferrals and concerning the operation of the compliance check and on criteria for assessing significant studies. 2007.
3. Smyth RL, Edwards AD. A major new initiative to improve treatment for children. Arch Dis Child 2006 91 (3 212 3.
4. Bradford Hill A. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine 1965 58 : 295 300.
5. Strom BL. Pharmacoepidemiology. 2nd ed. Chichester : John Wiley, 1994.
6. Medical Research Council Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948 2 : 769 83.
7. Doll R, Hill AB. Smoking and carcinoma of the lung. Preliminary report. Br Med J 1950 2 : 730 48.
8. Doll R, Hill AB. The mortality of doctors in relation to thier smoking habits. Br Med J 1954 228 : 1451 5.
9. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999 340 : 1377 82.
10. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond 1995 29 : 41 9.
11. Smyth RL, Van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of the ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994 343 : 85 6.
12. Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, Van Velzen D, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995 346 : 1247 51.
13. FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, et al. High-dose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. New England Journal of Medicine 1997 336 : 1283 9.
14. Committee on Safety of Medicines. Report of the committee on safety of medicines expert working group on the safety of selective serotonin reuptake inhibitor antidepressants (2004). 2005. The Stationery Office, UK.
15. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005 330 : 385 8.
16. Martinez C, Rietbrock SW, Wise L, Ashby D, Chick J, Moseley J, et al. Antidepressant treatment and the risk of fatal and non-fatal self-harm in first episode depression- a population- based case-control study. BMJ 2005 330 : 389 93.
17. Gunnell D, Ashby D. Antidepressants and suicide: what is the balance of benefit and harm? BMJ 2005 329 : 34 8.
18. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 1991 338 : 131 7.
19. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001 358 : 2069 73.
20. Wald NJ, Morris JK. Teleoanalysis: combining data from different types of study. BMJ 2003 327 : 616 8.
21. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995 274 : 1698 1702.